The dinucleotide AG, found at the 3' end of virtually all eukaryotic pre-mRNA introns, is thought to be essential for splicing. Reduction-of-function mutations in two Caenorhabditis ekgans genes, the receptor tyrosine kinase gene let-23 and the collagen gene dpy-10, both alter the AG at the end of a short (ca. 50-nucleotide) intron to AA. The in vivo effects of these mutations were studied by sequencing polymerase chain reaction-amplified reverse-transcribed RNA isolated from the two mutants. As expected, we find transcripts that splice to a cryptic AG, skip an exon, and retain an unspliced intron. However, we also find significant levels of splicing at the mutated 3' splice site (AA) and at nearby non-AG dinucleotides. Our results indicate that for short C. elegans introns an AG is not required for splicing at either the correct 3' splice site or incorrect sites.
The dinucleotide AG is an essential feature of the 3' splice acceptor site of eukaryotic pre-mRNA introns. A comparison of approximately 3,700 pre-mRNA introns from vertebrates, invertebrates, plants, yeasts, and viruses shows that the AG at the 3' end of introns is virtually invariant: all contain the ultimate nucleotide G, and only four exceptions (involving alternative splice sites) to the penultimate nucleotide A were found (27, 50) . All the introns of the nematode Caenorhabditis elegans analyzed to date also end with the dinucleotide AG (15) .
Consistent with its striking conservation, the invariant AG is functionally critical for proper splicing. Alteration of the invariant AG to either AA, AU, CG, GG, or UG inhibits splicing in vitro (1, 35, 45) . The importance of the dinucleotide AG is also supported by in vivo studies. Introns harboring point mutations in the AG dinucleotide are abnormally spliced in yeasts (1), Neurospora crassa (34) , and mammalian cells (25, 38) . Conversely, mutations that create an AG (e.g., AC mutated to AG) sometimes result in the selection of the newly created AG as a new 3' splice site (36, 57) .
The necessity of having an AG at the 3' end of introns also has implications for numerous human disorders. Diseases associated with point mutation of either the A or the G at the 3' end of an intron include analbuminemia (47) , ,-thalassemia (4), citrullinemia (30, 52) , cystic fibrosis (21) , debrisoquine polymorphism (22) , hemophilia (9) , familial type III hyperlipoproteinemia (10) , lipoprotein lipase deficiency (23) , ornithine transcarbamylase deficiency (8) , osteogenesis imperfecta (58) , Tay-Sachs disease (39) , and xeroderma pigmentosum (49) .
The in vivo consequences of altering the AG at a 3' splice site vary and generally fall into three classes: cryptic splicing, exon skipping, and a failure to splice. When the AG at the end of an intron is mutated or deleted, cryptic splicing can occur at an AG that is not normally used as a 3' splice site. This cryptic AG is usually, but not always, nearby and can be located downstream (1, 30, 34, 49, 52) or upstream of the original 3' splice site (4, 10, 25) . On the other hand, mutation or removal of the AG at the 3' end of an intron can sometimes result in exon skipping: the 5' end of the mutated intron is used as the donor splice site, and the 3' end of the next intron downstream is used as the acceptor splice site (38, 58) . As a result, the mutant intron, the next exon, and the next intron are all spliced out together. Lastly, an intron harboring a mutated or deleted AG sometimes remains unspliced (10, 52 ).
Here we report on the splicing defects associated with mutation of the invariant AG to an AA in two short C. elegans introns: the 53-nucleotide (nt) intron 16 of the let-23 gene and the 48-nt intron 2 of the dpy-10 gene. Both the number and the nature of the resulting splicing products are unprecedented. We have also analyzed a double AG to AA mutation in a longer 316-nt intron of let-23. Our results indicate that splicing in C. elegans does not require an AG at the 3' splice site, suggesting that elements other than an AG can direct the selection and usage of 3' splice sites. We discuss the implications of these findings to splicing in C. elegans and other organisms.
MATERIALS AND METHODS
We describe the materials and methods used for the let-23 and dpy-10 investigations separately since the studies were mostly carried out independently.
Localization of mutations. (i) kt-23(nl045) and let-23 (sy97sy122). The n1O45 mutation was localized and sequenced as described for the allele let-23(sy5) (2) . The n1045 intron 16 coding sequence and all exon/intron boundaries were examined multiple times for hydroxylamine polymorphisms, and only the intron 16 polymorphism was found. Furthermore, both genomic and cDNA sequence have been generated for more than 100 bases of either side of the n1045 mutation. No other mutation has been found. The mutation sy122 was isolated as an intragenic revertant of the let-23 allele sy97 (27b) . The specific alteration associated with this mutant was found by directly sequencing polymerase chain reaction (PCR)-amplified genomic DNA.
(ii) dpy-10(e128). The dpy-1O(el28) mutation was localized by PCR amplification of the entire dpy-10 gene from e128 genomic DNA and subsequent cloning of the products into pBS (Stratagene). Five independent clones were sequenced by using standard dideoxy sequencing and Sequenase version 2.0 (U.S. Biochemical Corp. with LiCl, and resuspended again. RNA from the wild-type strain (courtesy of Jane Mendel) was similarly extracted, except the animals were harvested during exponential growth. RNA from PS463 let-23(sy97sy122) unc-4(e120); him-S(e1490) newly starved nematodes was isolated by using the RNAzol B method (Tel-Test, Inc.).
(ii) dpy-10(e128). Liquid cultures of either dpy-1O(el28) or wild-type worms were grown at 20°C in worm growth media and OP50 and harvested before starvation (54 Fig. 1A ; CI'S5 primer sequence: 5'CTCATCTAGGTACAAAACGGAGC C3'; CTS3 primer sequence: 5'CCAAGCTTGTATGAGA TGAATGGCAACGG3'). A negative control was always performed with water as a substitute for the substrate.
Reverse transcription of sy97sy122 RNA and amplification were similarly performed.
To verify that splicing of upstream introns was occurring normally in n1045, primers from exons 13 and 15 were used in PCR amplification (data not shown). Only one band with the size expected for a wild-type splice was found. Amplification was also performed with primers from exons 15 and 17 and with primers from exons 15 and 18. The results suggested that intron 15 is also correctly spliced out and that no upstream exon skipping is taking place.
We also performed a control in which reverse transcriptase was left out of the reaction to verify that the n1045
bands are the result of reverse transcription of RNA (data not shown). Sixty micrograms of DNase-treated RNA was treated as described above for reverse transcription up to the addition of enzyme. The reaction mixture was then split into two tubes. In one tube, 200 units of reverse transcriptase was added; in the other, DEPC-treated water was added.
The tubes were incubated at 37°C for 1 h and then PCR amplified. The sample lacking reverse transcriptase produced no bands upon amplification, whereas the sample including reverse transcriptase produced all the expected bands.
(ii) dpy-10(e128). Reverse transcription-PCR analysis was performed as described previously (28 To determine whether the most slowly migrating band in Fig. 4 , lane 5, represents a heteroduplex, the two lower bands were cut out of gels, mixed, heated to 95°C for 5 min, and then slowly cooled. Gel electrophoresis of this mixture revealed three bands, the two original bands as well as the third, more slowly migrating species. In addition, the slowest band was excised from a gel, heated to 95°C for 5 min, and then slowly cooled. Gel electrophoresis of this sample resulted in the same three bands. 13, 1993 and cut with restriction enzymes to verify insert and size. Most minipreps were sequenced by using a primer from exon 17 (extending toward exon 16) starting at approximately 100 bases from the start of exon 17. Sequencing was performed by using standard double-stranded sequencing reactions and Sequenase version 2.0. Only one strand was sequenced. Point mutations were not detected as a result of PCR amplification. Some subclones, including those lacking exon 17, were sequenced by using vector primers. The wild-typesize band in sy97syl22 was similarly subcloned. Sequencing was performed by using a primer from exon 18. One of the subclones (described in the text) was over 100 nt shorter than the rest, evidently being a contaminant in the gelexcised wild-type-size band.
(ii) dpy-1O(el28). Reverse transcription-PCR products generated by using primers Dl and D2 were cut with SalI and SacI restriction enzymes, which cut just internal to these primers, yielding a 176-bp fragment (when normal splicing occurs). These fragments were cloned into pBS cut with SalI and Sac. Clones that contained approximately correctly sized inserts were selected as assayed by restriction analyses and were sequenced by using standard double-stranded dideoxy sequencing with Sequenase version 2.0 and a universal sequencing primer. RNase protection experiments were performed by using a standard protocol (37 (ii) dpy-1O(el28). To determine levels of dpy-10 message in e128 RNA, competitive quantitative PCR was used (18, 19) . This method used a known amount of competitive template which is coamplified in PCR along with the unknown quantity of cDNA from reverse-transcribed e128 RNA. The competitive template used was a genomic DNA clone of the dpy-10 gene, pAL5. Parallel samples, each containing 30 ng of reverse-transcribed e128 RNA and serially diluted amounts of pAL5 (ranging from 0.01 to 1.00 amol), were amplified by using D4 (5'-GATCTACCGGTGTGTCAC-3') and D2. Amplification with D4 and D2 of unspliced mRNA or genomic DNA yields a 268-bp fragment; amplification of spliced mRNA yields a 220-bp fragment. At the point where the cDNA and genomic DNA templates are amplified equally, the starting concentration of cDNA equals the concentration of the pAL5 template. However, since some of the dpy-10 transcripts are unspliced for intron 2, these transcripts yield a product that is the same size as the competitor, making it difficult to measure this point of equal intensity; also, for this reason, the amplified signal of the e128 RNA-cDNA is always lower than that of the wild type. We therefore took as the measure of equal concentrations the point at which the concentration of competitor DNA decreased the original RNA (cDNA) signal to one-half of its value with no competitor added. PCRs were carried out with 1.0 ,ul of [a-32P]dATP (>400 Ci/mmol), and the radioactivity in each band was then quantified with a Fujix BAS2000 Bio-Image Analyzer which determines radioactivity in units of phospho-stimulable luminescence. The same procedure was done with wild-type RNA. To control for differences in RNA preparations, the same competition was performed with the two RNAs by using sqt-l-specific primers. The sqt-1 gene is a cuticle collagen, which is similar in structure to dpy-10 (33). Its expression is presumably not affected by mutations in dpy-10.
RESULTS
let-23(nlO45) and dpy-1O(el28) 3 sequence to the mammalian epidermal growth factor receptor (2) . Genetic studies have shown that the let-23 receptor tyrosine kinase is required for viability past the first larval stage, for hermaphrodite fertility, and for the development of the posterior ectoderm, the hermaphrodite vulva, and the male spicules (3, 13) . Elimination of let-23 activity results in completely penetrant larval lethality (3). The dpy-10 gene is structurally and functionally quite different: dpy-10 encodes a cuticular collagen (35a) that is similar in structure to the other sequenced cuticle collagens (31) (32) (33) 60) . Mutations in the dpy-10 collagen gene often result in a dumpy phenotype such that the mutant nematodes are shorter and fatter than the wild type (7) . In addition, mutations in the dpy-10 gene can sometimes result in a roller phenotype-the nematodes roll while they move because of a helical twist of the cuticle and underlying structures (11) . Elimination of the dpy-10 collagen gene results in nematodes which are both dumpy and left-handed rollers (35a).
The let-23(nlO45) mutation was localized and sequenced as part of a structure-function study of let-23 (2a). Many alleles of let-23 have been isolated and genetically characterized (3, 13, 14) . The non-null, reduction-of-function allele n1O45 is particularly interesting because it appears to be defective in negative regulation of vulval development (3).
The n1045 allele was sequenced (see Materials and Methods), and it was found that the last base of intron 16 is altered from G to A (Fig. 1A) . This splicing mutation eliminates the invariant AG at the 3' splice site.
A number of dpy-10 alleles, including dpy-1O(e128), were also sequenced as part of a structure-function study. The allele dpy-1O(e128) reduces but does not eliminate dpy-10 function. Sequencing of the e128 allele revealed that the last nucleotide of intron 2 is altered from G to A (Fig. 1B) 22 (lane 5) , and 20 (lane 6) rounds. To the right, the sizes of the bands in the n1045 lane, the percentages that each n1045 band represents relative to all the bands in the nl045 lane, the numbers of subclones from each band sequenced, and the exon-intron structure of nlO45 transcripts found in each band are indicated (exon-intron structure is given as shown in Fig. 1A ). The exon-intron structure of the upper band is based on size only and not on sequence data. Seven subclones from the wild-type band were also sequenced as a control. There is a faint extra band in the wild-type lane. Since it is not at the size predicted for any splicing product, it could be caused by non-let-23-specific amplification. The weaker band immediately below the nl045 band at the size expected for a wild-type splice is probably the result of cryptic splicing at the AG 17 bases downstream of the normal 3' splice site.
to splicing. The significance of these results with respect to the function of the let-23 and dpy-10 genes will be discussed separately (2a, 35a) .
Splicing in ket-23(nl045). To ascertain the effect of the nl045 mutation on let-23 mRNA, we isolated total RNA from homozygous let-23(n1O45) hermaphrodites, reverse transcribed the RNA by using random primers, and then performed PCR amplification with primers from exon 16 and the 3' untranslated region in exon 18 . The results are shown in Fig. 2 We were surprised at the results of sequencing 11 subclones from the n1045 band at the size (372 nt) expected for a wild-type splice (Fig. 3) . In two subclones, a cryptic AG, 17 bases downstream of the mutated intron 16 3' splice site, was used as a 3' splice site. However, in five subclones, a splice had occurred where the splice occurs in the wild-type despite the fact that there was an AA and not an AG 3' acceptor. In the remaining four subclones, a cryptic AU (two different ones), GG, and UG were used as the 3' splice site. These four non-AG cryptic sites are all within 8 bases of the normal 3' splice site. Despite the great variation of 3' splice sites used, the normal 5' splice donor site of intron 16 was J.
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(1) (2) (31) (4.) f').) (6) 16 3' splice site in let-23(nlO45). Eleven subclones from the n1O45 band at the size expected for a wild-type splice product were sequenced. The splices inferred from that sequencing are shown. Lowercase letters denote the intron sequence; uppercase letters denote the exon sequence. The larger downward-pointing arrowhead indicates the 5' junction used for all splices and is the correct 5' splice site. The upward-pointing arrowheads indicate the 3' splice junctions used. The numbers beneath each arrowhead indicate the number of subclasses in which a given 3' splice site was found.
used for all spliced transcripts. It is possible that we have not identified all the transcripts found in let-23(nlO45) since some of the splice products are represented by single subclones.
As shown in Fig. 2 We quantitated the abundance of let-23 message in the n1045 mutant by RNase protection. We used two different let-23 antisense probes that are common to all let-23 transcripts and normalized to an actin antisense probe. The data indicate that the combined level of all let-23 transcripts in the n1045 mutant is elevated to approximately threefold that of the single let-23 message in the wild type. This result was verified with quantitative and competitive PCR experiments, which indicate that relative to the rol-6 collagen gene, the combined level of all let-23 messages in n1045 is elevated to roughly four-to fivefold that of the single let-23 message in the wild type (data not shown). A caveat to interpreting this result is that the physiologies of the nlO45 and wild-type strains might differ (e.g., there are many dead larvae associated with nJO45). Nonetheless, we conclude that the amount of let-23 transcript in n1045 is significant relative to the amount of let-23 transcript in the wild type.
Splicing in dpy-1O(e128). To determine the splicing behavior of the dpy-1O(eI28) mutant, reverse transcription and PCR amplification were performed with RNA isolated from e128 animals. The results are shown in Fig. 4 . Amplification of reverse-transcribed wild-type RNA results in a single 486-bp band, as expected for normal splicing of introns 1 and 2 (lane 4). Amplification of reverse-transcribed e128 RNA results in three bands (lane 5). The predominant band, representing about two-thirds of the total signal, appears at the size of the normally spliced product. A larger, 534-bp band appears at the size expected when intron 1 is normally spliced but intron 2 is unspliced. We have determined that a third band, which migrates more slowly than the other two bands, is a heteroduplex consisting of one strand of unspliced product and one strand of spliced product. Examples of such heteroduplexes have been previously reported (61, 64) . To determine whether exon skipping was occurring, primer D3 (Fig. 1B) was used for reverse transcription-PCR analysis. No product that would suggest that exon 3 is skipped in any e128 transcripts was detected (data not shown).
The reverse transcription-PCR products in the apparently normally spliced band at 486 bp were cloned, and 13 subclones were sequenced. Three distinct 3' splice sites were found to be used (Fig. 5) . In two clones, splicing occurred at the same location as in the wild type, despite the presence of the AA dinucleotide; in four clones, splicing occurred at an upstream AA acceptor at position -8 relative to the location .UCAAACGACGAG... 4 2 7
FIG. 5. Splicing near the intron 2 3' splice site in dpy-1O(e128). Thirteen subclones from the 486-nt e128 band (Fig. 4, lane 5) were sequenced. The splices inferred from the sequencing are shown. The results are represented as described in the legend to Fig. 3. of the wild-type 3' splice site; in the remaining seven, splicing occurred at the AG that immediately follows the mutated site, corresponding to position +2. As a control, two wild-type dpy-10 cDNAs were sequenced and found to splice at the expected 3' acceptor. Thus, consistent with the results for let-23(nlO45), the splicing machinery can still recognize and use the mutant splice site at least some of the time despite the absence of the universally conserved AG dinucleotide. Also surprising is the utilization of the acceptor at -8 that also consists of an AA rather than an AG dinucleotide.
To determine the level of dpy-10 transcripts in e128 RNA, we performed quantitative, competitive PCR (see Materials and Methods) (18, 19) . We performed these experiments with e128 and wild-type RNAs to determine whether a difference in dpy-10 transcript levels could be detected. To control for differences in the RNA preparations, competitive PCR was also carried out with e128 and wild-type RNAs by using primers from the sqt-1 collagen gene (33) .
The results are shown in Fig. 6 , in which we have charted the decrease in the intensity of the amplified cDNA band PSL (ordinate) as increasing amounts of competitor DNA are added (abscissa). The point at which the cDNA product decreases to one-half of its maximum signal (with no competitor added) represents the point at which the initial concentrations of DNA competitor and cDNA are equal. Figure 6A shows that the wild-type and e128 RNA preparations give nearly identical results when the sqt-I control cDNA is amplified, indicating that the levels of sqt-1 in the two RNAs are very similar. Thus, differences seen when the dpy-10 cDNAs are amplified are probably not due to differences between the two RNA preparations. Figure 6B shows the results of the dpy-10 competition. The point at which the cDNA band decreases to one-half of its original signal is at 0.07 and 0.11 amol of competitor DNA for e128 and wildtype RNA, respectively. We therefore estimate that the total level of dpy-10 message in e128 RNA is 65% of that in the wild type. Thus, as with let-23(nlO45), the unusual splicing products seen are occurring at significant levels relative to wild-type dpy-10 splicing products. Results of dpy-10 quantitation with primers D4 and D2. The level of cDNA in e128 is lower at all points than that of the wild type because a fraction of the dpy-10 cDNAs in e128 is unspliced and therefore runs at the same position as the competitor. Nonetheless, the point at which one-half competition is reached is unaffected. The estimate of the amount of dpy-10 transcript in the wild-type RNA is 0.11 amol, while in e128 RNA it is 0.07 amol. The competitor used is a plasmid clone containing the wild-type dpy-10 gene. Quantitation was performed by including a radiolabeled nucleotide in the PCR mix and the use of a phospho-imager. *, N2 RNA; *, e128 RNA; PSL, phospho-stimulable luminescence. . . . . . . . . . . . . . . .  _~~~~~. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Among the wild-type-size subclones, we did find a subclone that was significantly shorter. In this let-23(sy97sy122) transcript, the UUUCAG found just downstream of the let-23 stop codon (2) is used as the 3' splice site. The resulting transcript is 190 nt shorter than the wild type. Since we do not see a strong band at this size upon amplification of sy97sy122 cDNA, this transcript is probably a very minor component of sy97syl22 transcripts. The analysis of PCRamplified-reverse-transcribed wild-type RNA provides no indication that this site is used during wild-type splicing.
DISCUSSION
The results presented in this report indicate that the dinucleotide AG found at the 3' end of virtually all eukaryotic introns is not absolutely essential for proper splicing of C. elegans introns and that non-AG 3' splice acceptor sites can, in some circumstances, compete with AG 3' splice sites. In both of the non-null mutations let-23(n1045) and dpy-10(e128), the AG dinucleotides located at the 3' end of short introns (53 and 48 nt, respectively) are mutated to AA.
For let-23(n1045), this mutation results in at least nine transcripts, compared with one for the wild type. Of all the transcripts, 52% result from six different transcripts splicing at or near the 3' splice site of the wild-type intron 16 , 42% result from exon skipping (pairing of the 5' splice site of intron 16 with the 3' splice site of intron 17), 4 .5% result from a failure to splice out intron 16, and 1.5% result from failure to splice out both intron 16 and intron 17 . For dpy-10(e128), at least four transcript species are generated. Of all the transcripts, 67% result from three different transcripts splicing at or near the 3' splice site of the wild-type intron 2 and 33% result from a failure to splice out intron 2. RNA quantitation indicates that the splicing events seen in both n1045 and e128 are occurring at significant levels relative to those of the wild type.
For both let-23(n1045) and dpy-10(e128), the 3' splicing events seen at or near the mutated 3' splice site include splicing to the mutated site (now AA), splicing to a nearby cryptic AG (for e128, this AG is immediately adjacent to the wild-type 3' splice site), and splicing to nearby cryptic sites that are not AG (AA, AU, GG, and UG). These non-AG sites conserve either the penultimate nucleotide (A) or the ultimate nucleotide (G) of the wild-type 3' splice site (AG).
The nature and extent of unusual splicing seen in n1045 and e128 are virtually unprecedented. Although there are a few examples in yeasts of correct splicing to a mutated 3' splice site or of splicing to non-AG 3' splice sites (see below), we know of no other case in which mutation of the 3' splice site led to such high levels of correct splicing at the mutated 3' splice site or to such promiscuous splicing at nearby non-AG sites. The extent of other splicing products seen is also noteworthy.
We also analyzed splicing in the allele let-23(sy97sy122). In this double mutant, the AG at the end of let-23 intron 17 (316 nt) and the AG at the start of exon 18 are both mutated to AA. Splicing occurs exclusively at the AA at the end of intron 17, indicating that an AG is also not required for splicing of this longer intron.
Although our results are unusual, we note that the effects of the point mutations on splicing were determined in vivo and in the context of the entire gene. That the let-23 and dpy-10 mutations are independently isolated and that the genes let-23 and dpy-10 themselves are functionally unrelated suggests that our results are generalizable to other C. elegans introns.
Splicing in C. elegans. Splicing in C. elegans shares many features in common with splicing in other organisms (reviewed in reference 6). C. elegans genes with sequences similar to the RNA components of the Ul, U2, U4/U6, and U5 small nuclear ribonucleoproteins have been characterized and cloned previously (55, 56) . On the basis of these sequences, the C. elegans splicing machinery is likely to be similar to that of other eukaryotes (6) . Furthermore, the splice acceptor AG is conserved, and the consensus sequence at the 5' splice donor site of C. elegans introns is the same as that for vertebrates, including the invariant GU at the 5' splice site (15) . However, C. elegans introns are unusually short-greater than 64% are less than 75 nt, with a strong peak in the VOL. 13, 1993 634 AROIAN ET AL. distribution at 45 to 55 nt (6, 15) . In contrast, most introns of other higher eukaryotes are 75 to 2,000 nt long, and efficient splicing of these introns may require a minimal length of approximately 80 nt (63) . Hence, there may be elements of the C. elegans splicing apparatus which differ from those of higher eukaryotes to efficiently splice such a large percentage of small introns. Another invertebrate, Drosophila melanogaster, also has short introns (24) .
There are other unusual features of splicing in C. elegans. Many C. elegans introns lack a potential branch point sequence (pyrimidine-purine-A-pyrimidine or YRAY) such as is found in higher organisms (6, 15) . In addition, C. elegans introns have a highly conserved 3' splice site: UUUCAG, with a U present at -5 relative to the cleavage site in over 98% of the introns (6, 15) . Lastly, C. elegans introns, like plant introns, have an elevated A-U content just upstream of the 3' splice site that may be important for their processing (5, 62) . Conversely, just upstream of the 3' splice site of higher eukaryotic introns is the polypyrimidine stretch that is important for their splicing (44, 45, 48, 51) .
To determine whether C. elegans introns may be spliced differently from mammalian introns, the splicing of C. elegans short introns (about 50 nt) was assayed in mouse cells and HeLa cell extracts (29, 42) . In neither case did correct splicing occur. In only one of these two cases (42) , correct splicing was restored by lengthening the intron.
Intron 16 of let-23 and intron 2 of dpy-10 fit the above profile of C. elegans introns. They are both short (53 and 48 nt, respectively), relatively A-U rich, and fit the 3' splice site consensus sequence in five of six places. There are three potential branch point sequences (YRAY) in intron 16 of let-23 (located at -19, -28, and -43) and one in intron 2 of dpy-10 (located at -11). The YRAY sequence in dpy-10 is closer to the 3' splice site than is usual for a branch point sequence.
Our in vivo results indicate that for these short C. elegans introns, an AG is important, but not essential, for the first step of splicing, i.e., cleavage at an upstream 5' splice site. In both let-23(n1045) and dpy-10(e128) [the mutation let-23(sy97sy122) is discussed below], mutation of the AG results in some stable transcripts with an unspliced intron, indicating that the AG does influence the efficiency of the first step of splicing. However, we cannot exclude that this effect is indirect, e.g., the mutation at the 3' splice site could speed up the transport pathway. Nonetheless, splicing can occur without the AG, and, when it does, the correct 5' splice site is chosen. Thus, to the extent analyzed, the downstream AG does not influence the accuracy of cleavage at the 5' splice site.
Our results also indicate that for these introns AG is important, but not essential, for the second step of splicing, i.e., cleavage at the 3' splice site and exon ligation. In both let-23(n1045) and dpy-10(e128), splicing to the correct site occurs even though the splice acceptor was mutated from AG to AA. From this, and other non-AG splices seen, we can also conclude that an AG per se is not essential for cleavage and ligation at the 3' splice junction, although our data suggest that there must be a match to either the A or the G. This preference for an A in the penultimate position or a G in the ultimate position may reflect some base pairing interaction with a small nuclear RNA (e.g., Ul) (20 [and references therein] The C. elegans splicing machinery may derive intron-exon border information based on the AU versus the GC content, as has been proposed for splicing in plants (5, 62) . In both the wild type and the mutants, this information could position the machinery in the proper vicinity of the 3' splice site. Unlike the wild type, however, the site of subsequent cleavage and ligation is not perfectly determined. Analysis of the actual splices made (Table 1) suggests that the exact location of the splices in the mutants may depend on competition among several of the sequence elements discussed above: (i) an AG (i.e., any AG), (ii) the remainder of the C. elegans 3' splice site consensus (i.e., UUUC, with the highly conserved U underlined), (iii) an A-U-rich region, and (iv) a putative branch site sequence. For example, of the splices made in dpy-10(e128), all are downstream of an A-U-rich region. However, the non-AG splices made do have a U at position -5, whereas the AG(+2) splice does not. This contrasts with the wild-type case in which the splice occurs at an AG with a U at -5. On the other hand, the AG (+ 15) is not used, perhaps because it cannot compete with the other AG (+2) and because there is neither a U at -5 relative to this AG nor an A-U-rich region immediately upstream. For e128, there is no obvious role of potential branch point sequences in 3' splice selection. For let-23(nlO45), the analysis is similar. In all cases but the GG(+4) splice, a U exists at -5 relative to a non-AG splice. Furthermore, there is no U at -5 relative to the splice at the cryptic AG, and this splice is the only one not preceded by an A-U-rich region. As with e128, it may be that the cryptic AG can sometimes be ignored if other nearby dinucleotides contain other sequence elements important for splicing. Unlike all the splices made in the mutant, all four sequence elements are present in the wild-type gene. The GG (+4) splice is perhaps made without a U at -5 because, after AG, GG might be the best dinucleotide at the 3' splice acceptor site (12) .
We hypothesize that once the machinery is positioned at the 3' splice site, the location of cleavage and ligation is determined by an AG, an upstream motif related to UIJUC, the A-U-rich region itself, and, perhaps to a lesser extent, the presence of a suitable branch point sequence. In the wild-type let-23 and dpy-10 introns studied here, these preferences all cooperate so that splicing occurs at the proper position. When the normal AG is mutated, these preferences allow other potential sites to compete with each other for selection as the 3' splice site. Consistent with the notion that the four elements noted together contribute to delineate a 3' splice site, our data also indicate that no one element alone is absolutely required for splicing. We cannot discern any influence in the selection of the 3' splice sites by adjacent exonic nucleotides, as has been suggested for yeast cells (41) .
The presence of unspliced intron in the mutants but not in the wild type may indicate that in the mutants either a critical, timely recognition of the 3' splice site did not occur and these unspliced transcripts have escaped splicing altogether or the timing of splicing machinery is significantly slowed down and these unspliced transcripts have yet to be spliced. The presence of significant levels of exon skipping in n1045 suggests that the intron 17 3' splice site can efficiently compete with the mutated intron 16 3' splice region for splicing to the intron 16 5 ' splice donor site. Exon skipping may not be occurring with e128 because the size of the intron Implications for splicing in other organisms. Although our results may be a consequence of some unique aspect of splicing in C. elegans and therefore limited to C. elegans, there is some precedent for our results in yeasts and possibly mammals. Mutation of the AG at the 3' end of the yeast Saccharomyces cerevisiae actin intron (AG to GG or AC) results in low levels of in vitro and in vivo splicing at the correct (but mutated) 3' splice site (16, 59) . In the actin intron of the yeast Kluyveromyces lactis, a GG can compete with the normal AG as the 3' splice site (12) . Furthermore, in one study of human analbuminemia, although the AG at a 3' splice site was mutated to a GG, very low levels of albumin were still detected in the bloodstream, suggesting that trace amounts of correctly spliced transcripts were made (47) . In a study of steroid 21-hydroxylase deficiency in humans, S1 nuclease analysis of RNA suggested that a mutation which created a 3' splice site (AC to AG) resulted in three abnormal, closely spaced splicing products that use AG and AC as 3' splice sites (26) . It is also possible that results similar to ours have been missed in the past. Some previous studies have relied on S1 nuclease and/or gel analysis assays, which may be less sensitive than sequencing of PCR-amplified cDNAs. Thus, our results may not be unique to C. elegans.
As discussed above, our data also suggest that primary sequences apart from the AG and branch point sequence influence 3' splice site selection and that these primary sequences may have an incremental effect on defining the competitiveness of 3' splice sites. Consistent with our findings, there is growing evidence that elements besides the AG and branch point sequence (e.g., other primary sequences, secondary structures, and 5' splice sites) may influence the strength and selection of 3' splice sites (12, 40, 43, 44, 46, 63) .
The presence of exon skipping (exon 16-exon 18) and the VOL. 13, 1993 occasional inclusion of intron 17 (exon 16-intron 16-exon 17-intron 17-exon 18) in nlO45 RNAs suggest that the intron 16 mutation is affecting splicing of the downstream intron. These results, especially the latter, are consistent with the idea that splicing occurs in a unitary complex of multiple introns (38) or that an early step of splicing is exon definition (46) . According to this latter model, the inefficient association of the splicing machinery at the 3' splice site of intron 16 may affect the ability of the splicing apparatus to associate with the 5' splice site of intron 17. Finally, the findings of this study suggest a mechanism for generating diversity in mRNA transcripts-competition among many closely positioned 3' splice sites, some of which may not be AG. There are two relevant studies along these lines. One is mentioned above (26) . In the other, analyses of rat ax2,u globulin mRNAs suggest that transcript diversity for this family of genes may be generated in part by using closely positioned AGs and UGs as 3' splice sites (17) .
